APO Research
Talk to an analyst

APO RESEARCH · REPORT

Mesalamine

Mesalamine, also known as Mesalamine, or 5-aminosalicylic acid (5-ASA), is a medication used to treat inflammatory bowel disease, including ulcerative colitis and Crohn's disease. It is generally used for mildly to moderately severe disease. It is taken by mouth or rectally. The formulations which are taken by mouth appear to be similarly effective.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Mesalamine, also known as Mesalamine, or 5-aminosalicylic acid (5-ASA), is a medication used to treat inflammatory bowel disease, including ulcerative colitis and Crohn's disease. It is generally used for mildly to moderately severe disease. It is taken by mouth or rectally. The formulations which are taken by mouth appear to be similarly effective.

Selected research

Industry Growth & Trends

Global Mesalamine Industry Growth and Trends Forecast to 2032

26 December 2025100 pages

Choose your research edition.

Industry ResearchMesalamine Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Mesalamine Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Mesalamine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Mesalamine Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Mesalamine Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

Mesalamine, also known as Mesalamine, or 5-aminosalicylic acid (5-ASA), is a medication used to treat inflammatory bowel disease, including ulcerative colitis and Crohn's disease. It is generally used for mildly to moderately severe disease. It is taken by mouth or rectally. The formulations which are taken by mouth appear to be similarly effective.

The industry's leading manufacturers are Syntese A/S, Divis Laboratories, ipca Laboratories and Cambrex Corporation, which accounted for 23.74%, 14.71%, 6.44% and 6.35% of the global revenue share in 2019, respectively.

In terms of regions, the revenue share of Europe is the highest, reaching 41.11% in 2019.

Read the full market overview

Report Scope

This report provides a structured, data-driven view of the global Mesalamine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Mesalamine market size, estimates, and forecasts are presented in terms of sales volume (MT) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Mesalamine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Mesalamine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Mesalamine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Mesalamine Market by Company

Syntese A/S

Divis Laboratories

Cambrex Corporation

Ipca Laboratories

Hangzhou Brother

PharmaZell

Lianyungang Fengheng Biopharm

Lasa Loboratory

Erregierre SpA

Corden Pharma Bergamo

CTX Lifescience

Ishita Active Pharma Ingredients

YC Biotech (Jiangsu)

Xinxiang Tianfeng Fine Chemical

Mesalamine Segment by Type

Purity ≥ 97%

Purity ≥ 98%

Purity ≥ 99%

Mesalamine Segment by Application

Mesalazine Tablets

Mesalazine Capsules

Others

Mesalamine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mesalamine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Mesalamine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mesalamine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Mesalamine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Mesalamine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Purity ≥ 97% Table 2. Major Company of Purity ≥ 98% Table 3. Major Company of Purity ≥ 99% Table 4. Global Mesalamine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Mesalamine Sales by Type (2021-2026) & (MT) Table 6. Global Mesalamine Sales Market Share in Volume by Type (2021-2026) Table 7. Global Mesalamine Sales by Type (2021-2026) & (US$ Million) Table 8. Global Mesalamine Sales Market Share in Value by Type (2021-2026) Table 9. Global Mesalamine Price by Type (2021-2026) & (USD/Kg) Table 10. Global Mesalamine Sales by Type (2027-2032) & (MT) Table 11. Global Mesalamine Sales Market Share in Volume by Type (2027-2032) Table 12. Global Mesalamine Sales by Type (2027-2032) & (US$ Million) Table 13. Global Mesalamine Sales Market Share in Value by Type (2027-2032) Table 14. Global Mesalamine Price by Type (2027-2032) & (USD/Kg) Table 15. North America Mesalamine Sales by Type (2021-2026) & (MT) Table 16. North America Mesalamine Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Mesalamine Sales by Type (2021-2026) & (MT) Table 18. Europe Mesalamine Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Mesalamine Sales by Type (2021-2026) & (MT) Table 20. Asia-Pacific Mesalamine Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Mesalamine Sales by Type (2021-2026) & (MT) Table 22. Latin America Mesalamine Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Mesalamine Sales by Type (2021-2026) & (MT) Table 24. Middle East and Africa Mesalamine Sales by Type (2021-2026) & (US$ Million) Table 25. Mesalamine Industry Trends Table 26. Mesalamine Industry Drivers Table 27. Mesalamine Industry Opportunities and Challenges Table 28. Mesalamine Industry Restraints Table 29. Global Mesalamine Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Mesalamine Revenue Market Share by Company (2021-2026) Table 31. Global Mesalamine Sales by Company (2021-2026) & (MT) Table 32. Global Mesalamine Sales Share by Company (2021-2026) Table 33. Global Mesalamine Market Price by Company (2021-2026) & (USD/Kg) Table 34. Global Mesalamine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Mesalamine Major Company Production Sites and Headquarters Table 36. Global Mesalamine Company, Product Type & Application Table 37. Global Mesalamine Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Mesalamine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Mesalamine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Mesalamine Sales by Region (2021-2026) & (MT) Table 42. Global Mesalamine Sales Market Share in Volume by Region (2021-2026) Table 43. Global Mesalamine Sales by Region (2021-2026) & (US$ Million) Table 44. Global Mesalamine Sales Market Share in Value by Region (2021-2026) Table 45. Global Mesalamine Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 46. Global Mesalamine Sales by Region (2027-2032) & (MT) Table 47. Global Mesalamine Sales Market Share in Volume by Region (2027-2032) Table 48. Global Mesalamine Sales by Region (2027-2032) & (US$ Million) Table 49. Global Mesalamine Sales Market Share in Value by Region (2027-2032) Table 50. Global Mesalamine Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2027-2032) Table 51. Global Mesalamine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Mesalamine Sales by Application (2021-2026) & (MT) Table 53. Global Mesalamine Sales Market Share in Volume by Application (2021-2026) Table 54. Global Mesalamine Sales by Application (2021-2026) & (US$ Million) Table 55. Global Mesalamine Sales Market Share in Value by Application (2021-2026) Table 56. Global Mesalamine Price by Application (2021-2026) & (USD/Kg) Table 57. Global Mesalamine Sales by Application (2027-2032) & (MT) Table 58. Global Mesalamine Sales Market Share in Volume by Application (2027-2032) Table 59. Global Mesalamine Sales by Application (2027-2032) & (US$ Million) Table 60. Global Mesalamine Sales Market Share in Value by Application (2027-2032) Table 61. Global Mesalamine Price by Application (2027-2032) & (USD/Kg) Table 62. North America Mesalamine Sales by Application (2021-2026) & (MT) Table 63. North America Mesalamine Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Mesalamine Sales by Application (2021-2026) & (MT) Table 65. Europe Mesalamine Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Mesalamine Sales by Application (2021-2026) & (MT) Table 67. Asia-Pacific Mesalamine Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Mesalamine Sales by Application (2021-2026) & (MT) Table 69. Latin America Mesalamine Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Mesalamine Sales by Application (2021-2026) & (MT) Table 71. Middle East and Africa Mesalamine Sales by Application (2021-2026) & (US$ Million) Table 72. Syntese A/S Company Information Table 73. Syntese A/S Business Overview Table 74. Syntese A/S Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 75. Syntese A/S Mesalamine Product Portfolio Table 76. Syntese A/S Recent Development Table 77. Divis Laboratories Company Information Table 78. Divis Laboratories Business Overview Table 79. Divis Laboratories Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 80. Divis Laboratories Mesalamine Product Portfolio Table 81. Divis Laboratories Recent Development Table 82. Cambrex Corporation Company Information Table 83. Cambrex Corporation Business Overview Table 84. Cambrex Corporation Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 85. Cambrex Corporation Mesalamine Product Portfolio Table 86. Cambrex Corporation Recent Development Table 87. Ipca Laboratories Company Information Table 88. Ipca Laboratories Business Overview Table 89. Ipca Laboratories Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 90. Ipca Laboratories Mesalamine Product Portfolio Table 91. Ipca Laboratories Recent Development Table 92. Hangzhou Brother Company Information Table 93. Hangzhou Brother Business Overview Table 94. Hangzhou Brother Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 95. Hangzhou Brother Mesalamine Product Portfolio Table 96. Hangzhou Brother Recent Development Table 97. PharmaZell Company Information Table 98. PharmaZell Business Overview Table 99. PharmaZell Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 100. PharmaZell Mesalamine Product Portfolio Table 101. PharmaZell Recent Development Table 102. Lianyungang Fengheng Biopharm Company Information Table 103. Lianyungang Fengheng Biopharm Business Overview Table 104. Lianyungang Fengheng Biopharm Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 105. Lianyungang Fengheng Biopharm Mesalamine Product Portfolio Table 106. Lianyungang Fengheng Biopharm Recent Development Table 107. Lasa Loboratory Company Information Table 108. Lasa Loboratory Business Overview Table 109. Lasa Loboratory Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 110. Lasa Loboratory Mesalamine Product Portfolio Table 111. Lasa Loboratory Recent Development Table 112. Erregierre SpA Company Information Table 113. Erregierre SpA Business Overview Table 114. Erregierre SpA Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 115. Erregierre SpA Mesalamine Product Portfolio Table 116. Erregierre SpA Recent Development Table 117. Corden Pharma Bergamo Company Information Table 118. Corden Pharma Bergamo Business Overview Table 119. Corden Pharma Bergamo Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 120. Corden Pharma Bergamo Mesalamine Product Portfolio Table 121. Corden Pharma Bergamo Recent Development Table 122. CTX Lifescience Company Information Table 123. CTX Lifescience Business Overview Table 124. CTX Lifescience Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 125. CTX Lifescience Mesalamine Product Portfolio Table 126. CTX Lifescience Recent Development Table 127. Ishita Active Pharma Ingredients Company Information Table 128. Ishita Active Pharma Ingredients Business Overview Table 129. Ishita Active Pharma Ingredients Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 130. Ishita Active Pharma Ingredients Mesalamine Product Portfolio Table 131. Ishita Active Pharma Ingredients Recent Development Table 132. YC Biotech (Jiangsu) Company Information Table 133. YC Biotech (Jiangsu) Business Overview Table 134. YC Biotech (Jiangsu) Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 135. YC Biotech (Jiangsu) Mesalamine Product Portfolio Table 136. YC Biotech (Jiangsu) Recent Development Table 137. Xinxiang Tianfeng Fine Chemical Company Information Table 138. Xinxiang Tianfeng Fine Chemical Business Overview Table 139. Xinxiang Tianfeng Fine Chemical Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 140. Xinxiang Tianfeng Fine Chemical Mesalamine Product Portfolio Table 141. Xinxiang Tianfeng Fine Chemical Recent Development Table 142. North America Mesalamine Market Size Growth Rate (CAGR) by Country (MT): 2021 VS 2025 VS 2032 Table 143. North America Mesalamine Sales by Country (2021-2026) & (MT) Table 144. North America Mesalamine Sales Market Share by Country (2021-2026) Table 145. North America Mesalamine Sales Forecast by Country (2027-2032) & (MT) Table 146. North America Mesalamine Sales Market Share Forecast by Country (2027-2032) Table 147. North America Mesalamine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. North America Mesalamine Market Size by Country (2021-2026) & (US$ Million) Table 149. North America Mesalamine Market Share by Country (2021-2026) Table 150. North America Mesalamine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. North America Mesalamine Market Share Forecast by Country (2027-2032) Table 152. Europe Mesalamine Market Size Growth Rate (CAGR) by Country (MT): 2021 VS 2025 VS 2032 Table 153. Europe Mesalamine Sales by Country (2021-2026) & (MT) Table 154. Europe Mesalamine Sales Market Share by Country (2021-2026) Table 155. Europe Mesalamine Sales Forecast by Country (2027-2032) & (MT) Table 156. Europe Mesalamine Sales Market Share Forecast by Country (2027-2032) Table 157. Europe Mesalamine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Europe Mesalamine Market Size by Country (2021-2026) & (US$ Million) Table 159. Europe Mesalamine Market Share by Country (2021-2026) Table 160. Europe Mesalamine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Europe Mesalamine Market Share Forecast by Country (2027-2032) Table 162. Asia-Pacific Mesalamine Market Size Growth Rate (CAGR) by Country (MT): 2021 VS 2025 VS 2032 Table 163. Asia-Pacific Mesalamine Sales by Country (2021-2026) & (MT) Table 164. Asia-Pacific Mesalamine Sales Market Share by Country (2021-2026) Table 165. Asia-Pacific Mesalamine Sales Forecast by Country (2027-2032) & (MT) Table 166. Asia-Pacific Mesalamine Sales Market Share Forecast by Country (2027-2032) Table 167. Asia-Pacific Mesalamine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Asia-Pacific Mesalamine Market Size by Country (2021-2026) & (US$ Million) Table 169. Asia-Pacific Mesalamine Market Share by Country (2021-2026) Table 170. Asia-Pacific Mesalamine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Asia-Pacific Mesalamine Market Share Forecast by Country (2027-2032) Table 172. Latin America Mesalamine Market Size Growth Rate (CAGR) by Country (MT): 2021 VS 2025 VS 2032 Table 173. Latin America Mesalamine Sales by Country (2021-2026) & (MT) Table 174. Latin America Mesalamine Sales Market Share by Country (2021-2026) Table 175. Latin America Mesalamine Sales Forecast by Country (2027-2032) & (MT) Table 176. Latin America Mesalamine Sales Market Share Forecast by Country (2027-2032) Table 177. Latin America Mesalamine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 178. Latin America Mesalamine Market Size by Country (2021-2026) & (US$ Million) Table 179. Latin America Mesalamine Market Share by Country (2021-2026) Table 180. Latin America Mesalamine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 181. Latin America Mesalamine Market Share Forecast by Country (2027-2032) Table 182. Middle East and Africa Mesalamine Market Size Growth Rate (CAGR) by Country (MT): 2021 VS 2025 VS 2032 Table 183. Middle East and Africa Mesalamine Sales by Country (2021-2026) & (MT) Table 184. Middle East and Africa Mesalamine Sales Market Share by Country (2021-2026) Table 185. Middle East and Africa Mesalamine Sales Forecast by Country (2027-2032) & (MT) Table 186. Middle East and Africa Mesalamine Sales Market Share Forecast by Country (2027-2032) Table 187. Middle East and Africa Mesalamine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 188. Middle East and Africa Mesalamine Market Size by Country (2021-2026) & (US$ Million) Table 189. Middle East and Africa Mesalamine Market Share by Country (2021-2026) Table 190. Middle East and Africa Mesalamine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 191. Middle East and Africa Mesalamine Market Share Forecast by Country (2027-2032) Table 192. Key Raw Materials Table 193. Raw Materials Key Suppliers Table 194. Mesalamine Distributors List Table 195. Mesalamine Customers List Table 196. Research Programs/Design for This Report Table 197. Authors List of This Report Table 198. Secondary Sources Table 199. Primary Sources List of Figures Figure 1. Mesalamine Image Figure 2. Global Mesalamine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Mesalamine Market Size (2021-2032) & (US$ Million) Figure 4. Global Mesalamine Sales (2021-2032) & (MT) Figure 5. Purity ≥ 97% Image Figure 6. Global Purity ≥ 97% Sales YoY Growth (2021-2032) & (MT) Figure 7. Purity ≥ 98% Image Figure 8. Global Purity ≥ 98% Sales YoY Growth (2021-2032) & (MT) Figure 9. Purity ≥ 99% Image Figure 10. Global Purity ≥ 99% Sales YoY Growth (2021-2032) & (MT) Figure 11. Global Mesalamine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Mesalamine Market Share by Type 2025 VS 2032 Figure 13. North America Mesalamine Sales Market Share in Volume by Type in 2025 Figure 14. North America Mesalamine Sales Market Share in Value by Type in 2025 Figure 15. Europe Mesalamine Sales Market Share in Volume by Type in 2025 Figure 16. Europe Mesalamine Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Mesalamine Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Mesalamine Sales Market Share in Value by Type in 2025 Figure 19. Latin America Mesalamine Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Mesalamine Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Mesalamine Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Mesalamine Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Mesalamine Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Mesalazine Tablets Image Figure 26. Global Mesalazine Tablets Sales YoY Growth (2021-2032) & (MT) Figure 27. Mesalazine Capsules Image Figure 28. Global Mesalazine Capsules Sales YoY Growth (2021-2032) & (MT) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (MT) Figure 31. Global Mesalamine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Mesalamine Market Share by Application 2025 VS 2032 Figure 33. North America Mesalamine Sales Market Share in Volume by Application in 2025 Figure 34. North America Mesalamine Sales Market Share in Value by Application in 2025 Figure 35. Europe Mesalamine Sales Market Share in Volume by Application in 2025 Figure 36. Europe Mesalamine Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Mesalamine Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Mesalamine Sales Market Share in Value by Application in 2025 Figure 39. Latin America Mesalamine Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Mesalamine Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Mesalamine Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Mesalamine Sales Market Share in Value by Application in 2025 Figure 43. North America Mesalamine Sales by Country: 2021 VS 2025 VS 2032 (MT) Figure 44. North America Mesalamine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Mesalamine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Mesalamine Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Mesalamine Sales by Country: 2021 VS 2025 VS 2032 (MT) Figure 48. Europe Mesalamine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Mesalamine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Mesalamine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Mesalamine Sales by Country: 2021 VS 2025 VS 2032 (MT) Figure 52. Asia-Pacific Mesalamine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Mesalamine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Mesalamine Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Mesalamine Sales by Country: 2021 VS 2025 VS 2032 (MT) Figure 56. Latin America Mesalamine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Mesalamine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Mesalamine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Mesalamine Sales by Country: 2021 VS 2025 VS 2032 (MT) Figure 60. Middle East and Africa Mesalamine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Mesalamine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Mesalamine Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Mesalamine Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Mesalamine Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Purity ≥ 97%
  • Purity ≥ 98%
  • Purity ≥ 99%
Applications
  • Mesalazine Tablets
  • Mesalazine Capsules
  • Others
Companies covered
  • Syntese A/S
  • Divis Laboratories
  • Cambrex Corporation
  • Ipca Laboratories
  • Hangzhou Brother
  • PharmaZell
  • Lianyungang Fengheng Biopharm
  • Lasa Loboratory
  • Erregierre SpA
  • Corden Pharma Bergamo
  • CTX Lifescience
  • Ishita Active Pharma Ingredients
  • YC Biotech (Jiangsu)
  • Xinxiang Tianfeng Fine Chemical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Mesalamine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Mesalamine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Mesalamine Market by Type
  6. 1.3.1 Purity ≥ 97%
  7. 1.3.2 Purity ≥ 98%
  8. 1.3.3 Purity ≥ 99%
  9. 1.4 Global Mesalamine Market Size by Type
  10. 1.4.1 Global Mesalamine Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Mesalamine Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Mesalamine Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Mesalamine Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Mesalamine Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Mesalamine Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Mesalamine Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Mesalamine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Mesalamine Industry Trends
  2. 2.2 Mesalamine Industry Drivers
  3. 2.3 Mesalamine Industry Opportunities and Challenges
  4. 2.4 Mesalamine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Mesalamine Revenue (2021-2026)
  2. 3.2 Global Top Players by Mesalamine Sales (2021-2026)
  3. 3.3 Global Top Players by Mesalamine Price (2021-2026)
  4. 3.4 Global Mesalamine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Mesalamine Major Company Production Sites & Headquarters
  6. 3.6 Global Mesalamine Company, Product Type & Application
  7. 3.7 Global Mesalamine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Mesalamine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Mesalamine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Mesalamine Tier 1, Tier 2, and Tier 3
4 Mesalamine Regional Status and Outlook
  1. 4.1 Global Mesalamine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Mesalamine Historic Market Size by Region
  3. 4.2.1 Global Mesalamine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Mesalamine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Mesalamine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Mesalamine Forecasted Market Size by Region
  7. 4.3.1 Global Mesalamine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Mesalamine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Mesalamine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Mesalamine by Application
  1. 5.1 Mesalamine Market by Application
  2. 5.1.1 Mesalazine Tablets
  3. 5.1.2 Mesalazine Capsules
  4. 5.1.3 Others
  5. 5.2 Global Mesalamine Market Size by Application
  6. 5.2.1 Global Mesalamine Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Mesalamine Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Mesalamine Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Mesalamine Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Mesalamine Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Mesalamine Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Mesalamine Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Mesalamine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Syntese A/S
  2. 6.1.1 Syntese A/S Company Information
  3. 6.1.2 Syntese A/S Business Overview
  4. 6.1.3 Syntese A/S Mesalamine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Syntese A/S Mesalamine Product Portfolio
  6. 6.1.5 Syntese A/S Recent Developments
  7. 6.2 Divis Laboratories
  8. 6.2.1 Divis Laboratories Company Information
  9. 6.2.2 Divis Laboratories Business Overview
  10. 6.2.3 Divis Laboratories Mesalamine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Divis Laboratories Mesalamine Product Portfolio
  12. 6.2.5 Divis Laboratories Recent Developments
  13. 6.3 Cambrex Corporation
  14. 6.3.1 Cambrex Corporation Company Information
  15. 6.3.2 Cambrex Corporation Business Overview
  16. 6.3.3 Cambrex Corporation Mesalamine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Cambrex Corporation Mesalamine Product Portfolio
  18. 6.3.5 Cambrex Corporation Recent Developments
  19. 6.4 Ipca Laboratories
  20. 6.4.1 Ipca Laboratories Company Information
  21. 6.4.2 Ipca Laboratories Business Overview
  22. 6.4.3 Ipca Laboratories Mesalamine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Ipca Laboratories Mesalamine Product Portfolio
  24. 6.4.5 Ipca Laboratories Recent Developments
  25. 6.5 Hangzhou Brother
  26. 6.5.1 Hangzhou Brother Company Information
  27. 6.5.2 Hangzhou Brother Business Overview
  28. 6.5.3 Hangzhou Brother Mesalamine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Hangzhou Brother Mesalamine Product Portfolio
  30. 6.5.5 Hangzhou Brother Recent Developments
  31. 6.6 PharmaZell
  32. 6.6.1 PharmaZell Company Information
  33. 6.6.2 PharmaZell Business Overview
  34. 6.6.3 PharmaZell Mesalamine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 PharmaZell Mesalamine Product Portfolio
  36. 6.6.5 PharmaZell Recent Developments
  37. 6.7 Lianyungang Fengheng Biopharm
  38. 6.7.1 Lianyungang Fengheng Biopharm Company Information
  39. 6.7.2 Lianyungang Fengheng Biopharm Business Overview
  40. 6.7.3 Lianyungang Fengheng Biopharm Mesalamine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Lianyungang Fengheng Biopharm Mesalamine Product Portfolio
  42. 6.7.5 Lianyungang Fengheng Biopharm Recent Developments
  43. 6.8 Lasa Loboratory
  44. 6.8.1 Lasa Loboratory Company Information
  45. 6.8.2 Lasa Loboratory Business Overview
  46. 6.8.3 Lasa Loboratory Mesalamine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Lasa Loboratory Mesalamine Product Portfolio
  48. 6.8.5 Lasa Loboratory Recent Developments
  49. 6.9 Erregierre SpA
  50. 6.9.1 Erregierre SpA Company Information
  51. 6.9.2 Erregierre SpA Business Overview
  52. 6.9.3 Erregierre SpA Mesalamine Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Erregierre SpA Mesalamine Product Portfolio
  54. 6.9.5 Erregierre SpA Recent Developments
  55. 6.10 Corden Pharma Bergamo
  56. 6.10.1 Corden Pharma Bergamo Company Information
  57. 6.10.2 Corden Pharma Bergamo Business Overview
  58. 6.10.3 Corden Pharma Bergamo Mesalamine Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Corden Pharma Bergamo Mesalamine Product Portfolio
  60. 6.10.5 Corden Pharma Bergamo Recent Developments
  61. 6.11 CTX Lifescience
  62. 6.11.1 CTX Lifescience Company Information
  63. 6.11.2 CTX Lifescience Business Overview
  64. 6.11.3 CTX Lifescience Mesalamine Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 CTX Lifescience Mesalamine Product Portfolio
  66. 6.11.5 CTX Lifescience Recent Developments
  67. 6.12 Ishita Active Pharma Ingredients
  68. 6.12.1 Ishita Active Pharma Ingredients Company Information
  69. 6.12.2 Ishita Active Pharma Ingredients Business Overview
  70. 6.12.3 Ishita Active Pharma Ingredients Mesalamine Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Ishita Active Pharma Ingredients Mesalamine Product Portfolio
  72. 6.12.5 Ishita Active Pharma Ingredients Recent Developments
  73. 6.13 YC Biotech (Jiangsu)
  74. 6.13.1 YC Biotech (Jiangsu) Company Information
  75. 6.13.2 YC Biotech (Jiangsu) Business Overview
  76. 6.13.3 YC Biotech (Jiangsu) Mesalamine Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 YC Biotech (Jiangsu) Mesalamine Product Portfolio
  78. 6.13.5 YC Biotech (Jiangsu) Recent Developments
  79. 6.14 Xinxiang Tianfeng Fine Chemical
  80. 6.14.1 Xinxiang Tianfeng Fine Chemical Company Information
  81. 6.14.2 Xinxiang Tianfeng Fine Chemical Business Overview
  82. 6.14.3 Xinxiang Tianfeng Fine Chemical Mesalamine Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Xinxiang Tianfeng Fine Chemical Mesalamine Product Portfolio
  84. 6.14.5 Xinxiang Tianfeng Fine Chemical Recent Developments
7 North America by Country
  1. 7.1 North America Mesalamine Sales by Country
  2. 7.1.1 North America Mesalamine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Mesalamine Sales by Country (2021-2026)
  4. 7.1.3 North America Mesalamine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Mesalamine Market Size by Country
  6. 7.2.1 North America Mesalamine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Mesalamine Market Size by Country (2021-2026)
  8. 7.2.3 North America Mesalamine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Mesalamine Sales by Country
  2. 8.1.1 Europe Mesalamine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Mesalamine Sales by Country (2021-2026)
  4. 8.1.3 Europe Mesalamine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Mesalamine Market Size by Country
  6. 8.2.1 Europe Mesalamine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Mesalamine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Mesalamine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Mesalamine Sales by Country
  2. 9.1.1 Asia-Pacific Mesalamine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Mesalamine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Mesalamine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Mesalamine Market Size by Country
  6. 9.2.1 Asia-Pacific Mesalamine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Mesalamine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Mesalamine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Mesalamine Sales by Country
  2. 10.1.1 South America Mesalamine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Mesalamine Sales by Country (2021-2026)
  4. 10.1.3 South America Mesalamine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Mesalamine Market Size by Country
  6. 10.2.1 South America Mesalamine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Mesalamine Market Size by Country (2021-2026)
  8. 10.2.3 South America Mesalamine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Mesalamine Sales by Country
  2. 11.1.1 Middle East and Africa Mesalamine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Mesalamine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Mesalamine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Mesalamine Market Size by Country
  6. 11.2.1 Middle East and Africa Mesalamine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Mesalamine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Mesalamine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Mesalamine Value Chain Analysis
  2. 12.1.1 Mesalamine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Mesalamine Production Mode & Process
  7. 12.2 Mesalamine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Mesalamine Distributors
  10. 12.2.3 Mesalamine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst